TOMI™ Environmental Solutions, Inc. (“TOMI” or the “Company”)
(OTCQB: TOMZ), a global bacteria and infectious disease control company,
announced today that TOMI™ has received a $2.7 million
multi-year contract from La Caja del Seguro Social (“CSS”) Authorities
to start biomass reduction and decontamination services at The Complejo
Hospitalario Metropolitano in Panama City, Panama on October 1, 2013.
TOMI™ has started mobilization two weeks ago and has its
first team on the ground in Panama already. TOMI™ has
received an exclusive engagement from the La Caja del Seguro Social
(“CSS”) in Panama for biomass reduction and maintenance using its novel
SteraMist™ technology powered by BIT (Binary Ionization
Technology®).
During 2012, the Social Security General Director stated that if TOMI™
technology passed a 90-day pilot, then CSS would make TOMI’s technology
a standard within its healthcare system for the control of infectious
diseases. TOMI passed this 3-month trial pilot study, which was shown to
reduce HAI’s (Healthcare Associated Infections) significantly at
Complejo Hospitalario Metropolitano along with reducing deaths
associated to HAI’s.
Dr. Halden Shane, Chief Executive Officer of TOMI™,stated,
“I am thrilled that TOMI™ was chosen. Following a long due
diligence process, TOMI™ was granted the contract after
SteraMist’s six-log, residue-free green technology performance results
were chosen over other major international companies that specialize in
the decontamination space. This first $2.7 million contract, that covers
216,000 square meters using our SteraMist™ daily, is for 36
months and includes and initial 6,000 meter square biomass reduction.
Since winning this bid, TOMI™ has been contacted by
representatives of other foreign governments that are battling the daily
problem of deadly emerging viruses and bacteria in their healthcare
facilities.” In addition, Dr. Shane stated that “As a retired doctor,
there is nothing more rewarding than personally seeing
healthcare-associated infection death rates reduced as a direct result
of TOMI’s technology and its infectious disease protocols.”
Mark Futrovsky, TOMI’s President, stated, “We are excited and honored
that TOMI™ and its patented Binary Ionization Technology®
and service have been chosen by the Panamanian government to provide
solutions to combat these killer hospital-acquired infections and other
infectious diseases that Panama is currently experiencing. This project,
and those that are expected to follow in Panama, are consistent with
TOMI’s vision of delivering high-performing decontamination products and
services on a global basis.”
Sam Bergman, TOMI’s Chief Operating Officer, who is leading the team
that TOMI™ has sent into Panama, stated, “TOMI™
has a contract signed with La Caja Del Seguro Social (‘CSS’) and we will
comply with starting the Biomass Reduction and Decontamination Services
by October 1, 2013. We know that with TOMI’s Binary Ionization
Technology®, many hospital-acquired infections are completely
preventable. I am extremely privileged and humbled to be leading our
operational team in bringing this approach to Panama.”
Dr. Rolando Bissot, Deputy Director of Health Innovation and Development
for the La Caja del Seguro Social (“CSS”), stated, “Our healthcare
system has been very impressed with the results of SteraMist technology
along with the cleaning, infection control protocols and procedures that
TOMI™ offers. Since the 3-month trial pilot study at our
Complejo Hospitalario Metropolitano facility concluded, I have seen a
significant reduction in HAI’s on the ward that participated in the test
pilot at Complejo. I believe that with the implementation of TOMI’s
technology, protocols and procedures in our hospital systems, we are on
the right path in increasing our ability to deal with the Panamanian
public health issues as it relates to infection disease control.”
Guillermo Clement, General Manager of TOMI™ Panama S,
A., stated, “It is impressive the efficiency and flexibility of the
technology, the short time it takes to decontaminate rooms and achieve
Six-Log Kill. This really gave TOMI™ an edge in competing for
this project. We have been measuring additional areas in other public
hospitals which will go operational in the very near future.”
Jose Enrique Calvo L., Chief Executive Officer of TOMI™
Panama S, A., stated, “As a Panamanian, I am concerned about our
hospitals and the care of our patients, especially in light of the
deadly HAI’s that are multiplying exponentially — this is a war. Having
researched potential technologies, we have partnered with TOMI™,
America’s best, and its SteraMist state-of-the-art technology in the
global bacteria decontamination field. This way, we will save lives and
keep families together.”
About TOMI™ Environmental Solutions, Inc.
TOMI™ Environmental Solutions, Inc. (OTCQB: TOMZ) is a global
bacteria decontamination and infectious disease control company,
providing green energy-efficient environmental solutions for indoor
surface decontamination through manufacturing, sales and licensing of
our premier platform of Hydrogen Peroxide aerosols, Ultra-Violet Ozone
Generators and Ultra-Violet Germicidal Irradiation (“UVGI”) products and
technologies.
TOMI™’s products are designed to service a broad spectrum of
commercial structures including medical facilities, office buildings,
hotel and motel rooms, schools, restaurants, meat and produce processing
facilities, military barracks, and athletic facilities. TOMI™’s
products and services have also been used in single-family homes and
multi-unit residences.
TOMI™ also develops training programs and application
protocols for its clients and is a member in good standing with The
American Biological Safety Association, The American Association of
Tissue Banks, Association for Professionals in Infection Control and
Epidemiology, Society for Healthcare Epidemiology of America, The
Restoration Industry Association, Indoor Air Quality Association and The
International Ozone Association.
For additional product information, visit www.tomiesinc.com
or contact us at info@tomiesinc.com.
Safe Harbor Statement under the Private Securities Litigation Reform
Act of 1995
Certain written and oral statements made by us may constitute
“forward-looking statements” as defined in the Private Securities
Litigation Reform Act of 1995 (the “Reform Act”). Forward-looking
statements are identified by such words and phrases as “we expect,”
“expected to,” “estimates,” “estimated,” “current outlook,” “we look
forward to,” “would equate to,” “projects,” “projections,” “projected to
be,” “anticipates,” “anticipated,” “we believe,” “could be,” and other
similar phrases. All statements addressing operating performance,
events, or developments that we expect or anticipate will occur in the
future, including statements relating to revenue growth, earnings,
earnings-per-share growth, or similar projections, are forward-looking
statements within the meaning of the Reform Act. Because they are
forward-looking, they should be evaluated in light of important risk
factors that could cause our actual results to differ materially from
our anticipated results. The information provided in this document is
based upon the facts and circumstances known at this time. We undertake
no obligation to update these forward-looking statements after the date
of this release.
Copyright Business Wire 2013